Apogee Therapeutics, Common Stock Price on December 18, 2024
| APGE Stock | 45.81 1.37 2.90% |
If you're considering investing in Apogee Stock, it is important to understand the factors that can impact its price. As of today, the current price of Apogee Therapeutics, stands at 45.81, as last reported on the 30th of December, with the highest price reaching 46.81 and the lowest price hitting 44.94 during the day. Apogee Therapeutics, secures Sharpe Ratio (or Efficiency) of -0.0703, which signifies that the company had a -0.0703% return per unit of risk over the last 3 months. Apogee Therapeutics, Common exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Apogee Therapeutics,'s Mean Deviation of 2.9, risk adjusted performance of (0.05), and Standard Deviation of 3.88 to double-check the risk estimate we provide.
The current year's Total Stockholder Equity is expected to grow to about 398.9 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 13.8 B. . At present, Apogee Therapeutics,'s Price To Book Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price Fair Value is expected to grow to 1,931, whereas Price Earnings To Growth Ratio is forecasted to decline to 66.84. Apogee Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Apogee |
Sharpe Ratio = -0.0703
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | APGE |
Estimated Market Risk
| 3.95 actual daily | 35 65% of assets are more volatile |
Expected Return
| -0.28 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.07 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Apogee Therapeutics, is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Apogee Therapeutics, by adding Apogee Therapeutics, to a well-diversified portfolio.
Price Book 3.5494 | Book Value 12.552 | Enterprise Value 2.1 B | Shares Float 29.1 M | Shares Outstanding 43.4 M |
Related Headline
BBB Foods Headline on 18th of December 2024
3 US Growth Companies With Up To 16 percent Insider Ownershi... by finance.yahoo.com
As the United States market navigates through a period of heightened anticipation surrounding the Federal Reserves interest rate decisions, major indices like the Dow Jones Industrial Average are experiencing fluctuations, with stock futures pointing to a potential rebound. In such an environment, growth companies with significant insider ownership can often present compelling opportunities for investors seeking alignment between company leadership and shareholder interests.
Apogee Therapeutics, Valuation on December 18, 2024
It is possible to determine the worth of Apogee Therapeutics, on a given historical date. On December 18, 2024 Apogee was worth 48.24 at the beginning of the trading date compared to the closed value of 44.69. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Apogee Therapeutics, stock. Still, in general, we apply an absolute valuation method to find Apogee Therapeutics,'s value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Apogee Therapeutics, where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Apogee Therapeutics,'s related companies.
| Open | High | Low | Close | Volume | |
| 46.87 | 48.27 | 45.34 | 48.09 | 365,189 | |
12/18/2024 | 48.24 | 48.85 | 43.69 | 44.69 | 510,964 |
| 45.31 | 48.33 | 44.35 | 47.02 | 584,059 |
| Backtest Apogee Therapeutics, | | | Apogee Therapeutics, History | | | Apogee Therapeutics, Valuation | Previous | Next |
Apogee Therapeutics, Trading Date Momentum on December 18, 2024
| On December 19 2024 Apogee Therapeutics, Common was traded for 47.02 at the closing time. The top price for the day was 48.33 and the lowest listed price was 44.35 . The trading volume for the day was 584.1 K. The trading history from December 19, 2024 was a factor to the next trading day price growth. The overall trading delta against the next closing price was 5.21% . The overall trading delta against the current closing price is 4.41% . |
Apogee Therapeutics, Fundamentals Correlations and Trends
By evaluating Apogee Therapeutics,'s financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Apogee Therapeutics,'s main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Apogee financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Apogee Therapeutics, Stock history
Apogee Therapeutics, investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Apogee is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Apogee Therapeutics, will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Apogee Therapeutics, stock prices may prove useful in developing a viable investing in Apogee Therapeutics,
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 25 B | 13.8 B |
Apogee Therapeutics, Quarterly Net Working Capital |
|
Apogee Therapeutics, Stock Technical Analysis
Apogee Therapeutics, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Apogee Therapeutics, Period Price Range
Low | December 30, 2024
| High |
0.00 | 0.00 |
Apogee Therapeutics, Common cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Apogee Therapeutics, December 30, 2024 Market Strength
Market strength indicators help investors to evaluate how Apogee Therapeutics, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Apogee Therapeutics, shares will generate the highest return on investment. By undertsting and applying Apogee Therapeutics, stock market strength indicators, traders can identify Apogee Therapeutics, Common entry and exit signals to maximize returns
Apogee Therapeutics, Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Apogee Therapeutics,'s price direction in advance. Along with the technical and fundamental analysis of Apogee Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Apogee to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.30) | |||
| Total Risk Alpha | (0.39) | |||
| Treynor Ratio | (0.41) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Apogee Stock analysis
When running Apogee Therapeutics,'s price analysis, check to measure Apogee Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apogee Therapeutics, is operating at the current time. Most of Apogee Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of Apogee Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apogee Therapeutics,'s price. Additionally, you may evaluate how the addition of Apogee Therapeutics, to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |